Crowdonomics
Autonomix Medical, Inc.

Reg A+ · Equity · Jul 2023

ClosedReg A+Equity
via Digital Offering LLC · last checked Aug 16, 2026
Raised
$0 / $20M max
0% of ceiling
Investors
—
—
Estimated pre-money
$61.7M
—

Financials disclosed in this offering

FY2022 · hover for source
$0
−$2.0M
FY2022
RevenueNet income
Metric
FY2022 audited
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
-$1,990,477
Balance sheet
Cash
$864,618
Accounts receivable
$0
Total assets
$864,618
Long-term debt
$0
Total liabilities
$220,590
Other
Headcount
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. Jan 19, 2024
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  2. Sep 29, 2023
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. Sep 15, 2023
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  4. Aug 22, 2023
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$61.7M
Price / share$5.00
Price / share today$105.00
Shares offered4,000,000

Estimated, not stated: $5.00 × 12,336,571 securities outstanding.

$5.00 as sold; $105.00 after the Sep 2023 split (1:21) (Form 10-Q, p. 1).

Offering details

Target—
Max$20,000,000
Min investment—
OpenedJul 7, 2023
Deadline—
Days active1,191

Links & provenance

Source: SEC EDGAR
0001683168-23-004711
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.